Yes, Kesimpta acts as an immunosuppressant by reducing the activity of the immune system, specifically targeting B-cells. While this mechanism helps control MS symptoms, it also increases the risk of infections. Patients should avoid contact with people who have contagious infections and discuss their vaccination history with healthcare providers before starting treatment.
Alert: Order your 3-month supply by October 12 to help avoid potential customs delays.
Get Semaglutide for $184 or Ozempic for $329
